EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of hepatic transporter function in rats using dynamic gadoxetate-enhanced MRI: a reproducibility study

Ebony R Gunwhy, Catherine D G Hines, Claudia Green, Iina Laitinen, Sirisha Tadimalla, Paul D Hockings, Gunnar Schütz, J Gerry Kenna, Steven Sourbron, John C Waterton

Magnetic Resonance Materials in Physics, Biology and Medicine · 2024

DOI: 10.1007/s10334-024-01192-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance Materials in Physics, Biology and Medicine, 2024. Verfasst von Ebony R Gunwhy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Polaris, 18 Claremont Crescent, Sheffield, S10 2TA,…. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Liver, Contrast Media, Rats, Wistar. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Previous studies have revealed a substantial between-centre variability in DCE-MRI biomarkers of hepatocellular function in rats. This study aims to identify the main sources of variability by comparing data measured at different centres and field strengths, at different days in the same subjects, and over the course of several months in the same centre. Materials and methods 13 substudies were conducted across three facilities on two 4.7 T and two 7 T scanners using a 3D spoiled gradient echo acquisition. All substudies included 3–6 male Wistar-Han rats each, either scanned once with vehicle ( n = 76) or twice with either vehicle ( n = 19) or 10 mg/kg of rifampicin ( n = 13) at follow-up. Absolute values, between-centre reproducibility, within-subject repeatability, detection limits, and effect sizes were derived for hepatocellular uptake rate ( K trans ) and biliary excretion rate ( k bh ). Sources of variability were identified using analysis of variance and stratification by centre, field strength, and time period.

Results

Data showed significant differences between substudies of 31% for K trans ( p = 0.013) and 43% for k bh ( p < 0.001). Within-subject differences were substantially smaller for k bh (8%) but less so for K trans (25%). Rifampicin-induced inhibition was safely above the detection limits, with an effect size of 75 ± 3% in K trans and 67 ± 8% in k bh . Most of the variability in individual data was accounted for by between-subject ( K trans = 23.5%; k bh = 42.5%) and between-centre ( K trans = 44.9%; k bh = 50.9%) variability, substantially more than the between-day variation ( K trans = 0.1%; k bh = 5.6%). Significant differences in k bh were found between field strengths at the same centre, between centres at the same field strength, and between repeat experiments over 2 months apart in the same centre.

Discussion

Between-centre bias caused by factors such as hardware differences, subject preparations, and operator dependence is the main source of variability in DCE-MRI of liver function in rats, closely followed by biological between-subject differences. Future method development should focus on reducing these sources of error to minimise the sample sizes needed to detect more subtle levels of inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingLiverContrast MediaRats, WistarGadolinium DTPARifampinAnimalsRatsMaleReproducibility of Results

Stichwörter der Autor:innen

Chemical and drug induced liver injuryGadolinium ethoxybenzyl DTPAMagnetic resonance imagingRatsReproducibility of results

Substanzen

gadolinium ethoxybenzyl DTPAContrast MediaGadolinium DTPARifampin

Autor:innen und Institutionen

  • Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Polaris, 18 Claremont Crescent, Sheffield, S10 2TA, UK. e.gunwhy@sheffield.ac.uk.
  • GSK, Collegeville, Collegeville, P.A., USA.
  • MR & CT Contrast Media Research, Bayer AG, Berlin, Germany.
  • Antaros Medical, GoCo House, Mölndal, Sweden.
  • Sanofi-Aventis GmbH, Frankfurt, Germany.
  • Institute of Medical Physics, University of Sydney, Sydney, Australia.

Förderung

  • Innovative Medicines Initiative

Zitieren

APA

Gunwhy, E. R., Hines, C. D. G., Green, C., Laitinen, I., Tadimalla, S., Hockings, P. D., Schütz, G., Kenna, J. G., Sourbron, S., & Waterton, J. C. (2024). Assessment of hepatic transporter function in rats using dynamic gadoxetate-enhanced MRI: a reproducibility study. Magnetic Resonance Materials in Physics, Biology and Medicine. https://doi.org/10.1007/s10334-024-01192-5

Vancouver

Gunwhy ER, Hines CDG, Green C, Laitinen I, Tadimalla S, Hockings PD, et al. Assessment of hepatic transporter function in rats using dynamic gadoxetate-enhanced MRI: a reproducibility study. Magnetic Resonance Materials in Physics, Biology and Medicine. 2024. doi:10.1007/s10334-024-01192-5

BibTeX
@article{Gunwhy2024,
  author = {Gunwhy, Ebony R and Hines, Catherine D G and Green, Claudia and Laitinen, Iina and Tadimalla, Sirisha and Hockings, Paul D and Schütz, Gunnar and Kenna, J Gerry and Sourbron, Steven and Waterton, John C},
  title = {Assessment of hepatic transporter function in rats using dynamic gadoxetate-enhanced MRI: a reproducibility study},
  journal = {Magnetic Resonance Materials in Physics, Biology and Medicine},
  year = {2024},
  doi = {10.1007/s10334-024-01192-5}
}
Kostenlos starten →